Assessing Neurological Outcomes After Atrial Fibrillation Ablation
This study is looking at how early Catheter Ablation (a procedure using heat or cold to correct heart rhythm problems) affects people who have had a stroke and are newly diagnosed with Atrial Fibrillation (AFib, an irregular heartbeat). Researchers want to see if this treatment improves how well you recover after a stroke. You might be able to join if you are over 18, recently had a stroke with new AFib, and have a Modified Rankin Scale (mRS) score less than 6 (meaning you have some disability but are not severely disabled). The study will measure your functional neurologic outcome (how well you can do daily activities) and whether you have another stroke over 12 months. The study plans to enroll 100 participants.
- Study design
- This is an observational study, meaning researchers will watch and collect information without assigning specific treatments. It plans to enroll 100 participants.
- What's involved
- Participants will be followed at 1, 3, 6, 9, and 12 months to measure outcomes.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after discharge.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
At a glance
Conditions
NCT06783868
Where you'd take part
This study runs at 7 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Centerpoint Medical Center
Independence, Missourino site contact published
Centerpoint Medical Center Clinic
Independence, Missourino site contact published
Kansas City Heart Rhythm Institute - Roe Clinic
Overland Park, Kansasno site contact published
Menorah Medical Center
Overland Park, Kansasno site contact published
Overland Park Regional Medical Center
Overland Park, Kansasno site contact published
Research Medical Center
Kansas City, Missourino site contact published
Research Medical Center Clinic
Kansas City, Missourino site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Dhanunjaya Lakkireddy, MD · PRINCIPAL_INVESTIGATOR · Kansas City Heart Rhythm Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Functional neurologic outcome - Modified Rankin Scale1 Month, 3 Months, 6 Months, 9 Months and 12 Months
Modified Rankin Scale is widely used to assess neurologic dysfunction in a broad range of neurologic and neurosurgical conditions. It is a 6-level ordinal outcome scale (0-5) used to assess the functional status of patients, encoding the range from no symptoms or functional impairment (mRS = 0) to severe disability requiring constant nursing care (mRS = 5)
- Recurrent Stroke12 Months
A recurrent stroke is when a person has another stroke following their first stroke. Experiencing one can have a major impact on a person's quality of life.